Overview

The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy

Status:
RECRUITING
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
Evaluating the long-term therapeutic effects and safety of hydroxychloroquine(compared to glucocorticoid therapy alone) in patients with inflammatory cardiomyopathy--a multicenter randomized controlled study
Phase:
PHASE2
Details
Lead Sponsor:
Tongji Hospital
Collaborators:
Taihe Hospital
Wuhan Central Hospital
Treatments:
Hydroxychloroquine
Prednisolone